News
4 Steps to Becoming a 401(k) Millionaire
Though saving $1 million for retirement won't guarantee you financial security in your senior years, a nest egg of that size should be enough to allow you to approach them with confidence. Of
Market Crash 2.0: 3 Stocks to Save Your Portfolio
The stock market's gallop out of bear territory after the March market crash screeched to a halt this month. After climbing 47% from this year's low point, the S&P 500 has dropped 5.4% since Sept
The 3 Best-Performing IPOs of 2020
Investing in IPOs is inherently risky, as many companies nowadays go public at exuberant valuations in order to raise as much money as quickly as possible. But if excited investors aren't careful,
5 Safe Stocks to Buy if the Stock Market Crashes
If we've learned anything about the stock market in 2020, it's that it's entirely unpredictable in the short term.
Though the broader market has conclusively shown that it increases in value over
Is Big Tech Putting Teladoc's Future in Jeopardy?
In the 1930s, 40% of patient encounters with a doctor occurred in the home. By the late 1980s, house calls were down to less than 1% of all physician encounters. It would seem that telehealth could
This Warren Buffett Advice Will Lower Your Tax Bill
Warren Buffett's investment advice is highly regarded, since he has had great success growing his fortune through prudent investments. But listening to Buffett might do more than just help you make
Aurora Cannabis Stock: Love It or Leave It?
Canadian marijuana company Aurora Cannabis (NYSE: ACB) had a dreadful 2019; its stock lost 56% of its value over the year, compared with a 36% decline in the industry benchmark Horizons Marijuana
Will Big Pharma Acquire Novavax?
Novavax (NASDAQ: NVAX) has had a phenomenal year in 2020. The mid-cap opened in January as a micro-cap, starting off the year at $4 a share. Nine months later, its shares are trading hands for $113
3 Signs You Should Steer Clear of the Stock Market Right Now
Investing in the stock market can be daunting for even the most experienced investors, especially when we're in the middle of a particularly volatile year.
While in many cases it's best to simply
Should You Buy or Sell Aurora Cannabis Now?
Aurora Cannabis (NYSE: ACB) released its fourth-quarter results on Sept. 22 and they were yet another disappointment, with the company reporting a loss of 1.9 billion Canadian dollars for the period
3 Dates for Investors to Circle in October
The first nine months of 2020 have been insane, and the 10th is already shaping to be a doozy. A lot can -- and will -- happen between now and Halloween.
We've got earnings season about to get
2 Under-the-Radar Biotech Stocks You'll Wish You Didn't Ignore
If you're looking for under-the-radar stocks to buy, there's no better place to start your search than the biotech industry. Hardly a week goes by without at least one new biotechnology company
7 Reasons Social Security Is in Big Trouble
Over the past eight-plus decades, we've watched Social Security grow into the most important social program in this country. Today, close to 65 million people receive a monthly payout from the
Is Now a Good Time to Buy Moderna Stock?
Moderna's (NASDAQ: MRNA) stock has cooled off in recent weeks; currently at about $70, it's nowhere near the highs of more than $95 that it reached in mid-July. For investors who want to add the
3 Popular Robinhood Stocks That May Go Bankrupt
A wild year of volatility for equities has brought investors of all sorts out of the woodwork. Although the ferocity of the first-quarter decline was a bit unnerving for all, it provided one heck of
2 Top Marijuana Stocks to Buy for the Long Term
Even before the legalization of marijuana in Canada in 2018, cannabis companies were busy investing billions of dollars in facilities to meet implausible demand projections, as well as acquiring
Bristol Myers Squibb Drug Combination Wins FDA Approval for Mesothelioma
Bristol Myers Squibb (NYSE: BMY) capped the week with a new approval from the Food and Drug Administration (FDA). On Friday, the regulator gave the green light for two of the pharmaceutical giant's
Why Isn’t Everyone Investing in Stocks?
In this week's episode of Motley Fool Money, Chris Hill chats with Motley Fool analysts Jason Moser and Andy Cross about the latest headlines and quarterly reports from Wall Street. They've got the
Why Janus Henderson Group Blasted 16% Higher on Friday
Financial services company Janus Henderson Group (NYSE: JHG) experienced a sudden jolt of interest from investors on Friday.
On news that investment boutique Trian Fund Management -- headed by a
There Was No Stock Market Panic Today. Are Investors Smarter?
The stock market finished lower on Friday, but the size of the move lower was relatively contained. Although the Nasdaq Composite finished with declines of more than 2%, the damage to the Dow Jones
Why Pinterest Stock Climbed 13% Last Month
Shares of Pinterest (NYSE: PINS) were moving higher after the virtual pin-board operator got a boost from some bullish analyst ratings and became the top downloaded app in the middle of the month
Amazon Music Teams With Universal Music to Remaster Thousands of Songs For Ultra HD
Friday was a good day for music aficionados, as Amazon (NASDAQ: AMZN) announced that its Amazon Music service is part of an effort to remaster "thousands" of songs for the Ultra High-Definition
President Trump Received Regeneron's Experimental Antibody Treatment for COVID-19
President Trump received an experimental antibody treatment to treat a confirmed case of COVID-19, according to a White House memo the President's physician, Dr. Sean P. Conley, issued on Friday
What You Need to Know About Nikola's Downfall
Just three months ago, car manufacturer Nikola Motors (NASDAQ: NKLA) was being lauded for pushing the limits of the auto industry, and its stock soared following its IPO. Then came the bad news. And
Why DraftKings Stock Soared 66% Higher in September
Shares of DraftKings (NASDAQ: DKNG) soared a whopping 66.4% higher in September, according to data provided by S&P Global Market Intelligence. It was almost non-stop positive press for the company